Brain MRI atrophy quantification in MS: From methods to clinical application.

Brain MRI atrophy quantification in MS: From methods to clinical application.

Patients with the main clinical phenotypes of multiple sclerosis (MS) manifest varying degrees of brain atrophy beyond that of normal aging. Assessment of atrophy helps to distinguish clinically and cognitively deteriorating patients and predicts those who will have a less-favorable clinical outcome...

Bibliografski detalji
Glavni autori:	Rocca, M, Battaglini, M, Benedict, R, De Stefano, N, Geurts, J, Henry, R, Horsfield, M, Jenkinson, M, Pagani, E, Filippi, M
Format:	Journal article
Jezik:	English
Izdano:	American Academy of Neurology 2016

Slični predmeti

Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI
od: Houshang Amiri, i dr.
Izdano: (2018-01-01)

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis.
od: Vrenken, H, i dr.
Izdano: (2013)

Recommendations to improve imaging and analysis of brain lesion load and atrophy in longitudinal studies of multiple sclerosis
od: Vrenken, H, i dr.
Izdano: (2013)

Relaxometry and brain myelin quantification with synthetic MRI in MS subtypes and their associations with spinal cord atrophy
od: Theodoros Ladopoulos, i dr.
Izdano: (2022-01-01)

Measurement of whole-brain and gray matter atrophy in multiple sclerosis: assessment with MR imaging
od: Storelli, L, i dr.
Izdano: (2018)

Measuring brain atrophy in multiple sclerosis.
od: De Stefano, N, i dr.
Izdano: (2007)

Improved MRI-derived assessment of grey and white matter volumes by using SIENAX
od: Battaglini, M, i dr.
Izdano: (2013)

SIENA-XL for improving the assessment of gray and white matter volume changes on brain MRI
od: Battaglini, M, i dr.
Izdano: (2017)

Enhanced brain extraction improves the accuracy of brain atrophy estimation.
od: Battaglini, M, i dr.
Izdano: (2008)

Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
od: Korteweg, T, i dr.
Izdano: (2009)

PREDICTING BRAIN ATROPHY AT 1 YEAR BY BASELINE MULTIMODAL MRI DATA
od: Tarunya, A, i dr.
Izdano: (2010)

Brain atrophy assessment in multiple sclerosis: importance and limitations.
od: Giorgio, A, i dr.
Izdano: (2008)

New automated brain extraction procedure improves the measurement of brain atrophy on conventional MR images
od: Battaglini, M, i dr.
Izdano: (2007)

Homocysteine and brain atrophy on MRI of non-demented elderly.
od: den Heijer, T, i dr.
Izdano: (2003)

MAGNIMS recommendations for harmonization of MRI data in MS multicenter studies
od: Nicola De Stefano, i dr.
Izdano: (2022-01-01)

MRI criteria for MS in patients with clinically isolated syndromes.
od: Montalban, X, i dr.
Izdano: (2010)

SIENA: Single and multiple time point brain atrophy analysis
od: Smith, S, i dr.
Izdano: (2001)

Evaluating and reducing the impact of white matter lesions on brain volume measurements.
od: Battaglini, M, i dr.
Izdano: (2012)

Evidence of early cortical atrophy in MS: relevance to white matter changes and disability.
od: De Stefano, N, i dr.
Izdano: (2003)

Role of artificial intelligence in MS clinical practice
od: Raffaello Bonacchi, i dr.
Izdano: (2022-01-01)

Deep learning-based quantification of brain atrophy using 2D T1-weighted MRI for Alzheimer’s disease classification
od: Chae Jung Park, i dr.
Izdano: (2024-08-01)

Visual scale of MRI evaluation of the brain atrophy on early stage of Alzheimer disease
od: N. G. Neznanov, i dr.
Izdano: (2018-07-01)

MRI brain T1 relaxation time changes in MS patients increase over time in both the white matter and the cortex.
od: Parry, A, i dr.
Izdano: (2003)

Progressive brain atrophy and clinical evolution in Parkinson’s disease
od: Massimo Filippi, i dr.
Izdano: (2020-01-01)

Distinguishing the brain MRI features of MS, AQP4-and MOG-antibody disease.
od: Jurynczyk, M, i dr.
Izdano: (2016)

Functional and structural brain networks in posterior cortical atrophy: A two-centre multiparametric MRI study
od: Federica Agosta, i dr.
Izdano: (2018-01-01)

Regional brain stem atrophy in idiopathic Parkinson's disease detected by anatomical MRI.
od: Thomas Jubault, i dr.
Izdano: (2009-12-01)

Optimizing full-brain coverage in human brain MRI through population distributions of brain size
od: Mennes, M, i dr.
Izdano: (2014)

Optimizing full-brain coverage in human brain MRI through population distributions of brain size.
od: Mennes, M, i dr.
Izdano: (2014)

Intercenter differences in diffusion tensor MRI acquisition.
od: Pagani, E, i dr.
Izdano: (2010)

High throughput method for detecting murine brain atrophy using a clinical 3T MRI
od: Michael Linzey, i dr.
Izdano: (2023-11-01)

Brain atrophy measurement over a MRI scanner change in multiple sclerosis
od: Tim Sinnecker, i dr.
Izdano: (2022-01-01)

Bacterial Porphyrin Extraction and Quantification by LC/MS/MS Analysis
od: Stefano Mancini, i dr.
Izdano: (2015-10-01)

Abnormal connectivity of the sensorimotor network in patients with MS: a multicenter fMRI study.
od: Rocca, M, i dr.
Izdano: (2009)

Brain atrophy pattern in patients with mild cognitive impairment: MRI study
od: Calandrelli Rosalinda, i dr.
Izdano: (2022-09-01)

Accurate GM atrophy quantification in MS using lesion-filling with co-registered 2D lesion masks
od: V. Popescu, i dr.
Izdano: (2014-01-01)

Brain Atrophy in Clinically Isolated Syndrome
od: J.I. Rojas, i dr.
Izdano: (2010-01-01)

The spatio-temporal relationship between white matter lesion volume changes and brain atrophy in clinically isolated syndrome and early multiple sclerosis
od: Rozemarijn M. Mattiesing, i dr.
Izdano: (2022-01-01)

A diagnosis model for brain atrophy using deep learning and MRI of type 2 diabetes mellitus
od: Saba Raoof Syed, i dr.
Izdano: (2023-10-01)

Validation data for the quantification of the Annonaceous acetogenin annonacin in Rat brain by UPLC-MS/MS
od: Natacha Bonneau, i dr.
Izdano: (2016-06-01)